This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian or other solid cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.
Additional locations may be listed on ClinicalTrials.gov for NCT06295965.
Locations matching your search criteria
United States
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer ConsortiumStatus: Active
Contact: Swisher Lab Research Coordinators
Phone: 206-616-8927
PRIMARY OBJECTIVE:
I. To understand the development of secondary myeloid cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome in patients with OC.
OUTLINE: This is an observational study.
Patients undergo blood sample collection and complete surveys on study. Patients' medical records are also reviewed.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationFred Hutch/University of Washington/Seattle Children's Cancer Consortium
Principal InvestigatorElizabeth Mary Swisher
